BackAcelyrin Overview

Acelyrin Current Assets

Latest current assets for SLRN: $430M.

Get informed when a big investor buys or sells

+ Follow
Current Assets
$429.49M
38.11% YoYΔ $-264.49M vs prior year quarter

Peer trimmed avg / median

Loading

Acelyrin Current Assets History

Loading

Acelyrin vs. peers: Current Assets Comparison

Loading

Acelyrin Current Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Acelyrin (SLRN) FAQ

As of the most recent data (March 2025), SLRN shows a current assets of $430M. That compares with $690M in the prior-year period — down 38.1% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, SLRN's current assets is now $430M (was $690M) — a 38.1% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Acelyrin is outperforming or lagging.

Tracking SLRN's current assets over time shows whether Acelyrin is scaling, shrinking, or reshaping that part of the business. The current reading is $430M That compares with $690M in the prior-year period — down 38.1% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this current assets page, Stockcircle has Acelyrin's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect current assets (currently $430M) with ownership activity and broader fundamentals.